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582A case-matched validation study of anatomic
severity grade score in predicting reinterventions
after endovascular aortic aneurysm repair
Patricia G. Johnson, BS, Candice R. Chipman, MD, Sadaf S. Ahanchi, MD, Jung H. Kim, MPH,
David J. Dexter, MD, and Jean M. Panneton, MD, Norfolk, Va
Background: In 2002, the Society for Vascular Surgery created the anatomic severity grading (ASG) score to classify
abdominal aortic aneurysms (AAAs). Our objective was to identify the predictive capability and cutoff value of preop-
erative ASG score for reintervention after endovascular aneurysm repair (EVAR).
Methods: We completed a retrospective review of AAA patients treated with elective EVAR from 2007 through 2011.
Patients who had reinterventions as well as preoperative M2S (M2S Inc, West Lebanon, NH) three-dimensional
reconstructions were identiﬁed and compared with a case-matched control group of patients without reintervention.
ASG component scores (neck, aortic, and iliac) and total ASG scores were calculated using M2S software.
Results: Of the 623 patients treated with EVAR, 79 (13%) had reinterventions of which 45 had preoperative M2S three-
dimensional reconstructions available for ASG score calculation. The reintervention group (mean age, 74 6 8; 80% male)
had a mean ASG score of 18 6 5 (range, 8-30) compared with a cohort of 45 EVAR patients (mean age, 74 6 7; 80%
male) who had a mean ASG score of 13 6 4 (range, 6-21; P < .0001). The mean AAA diameter for all patients was
52 mm 6 14 and was not signiﬁcantly different between the groups.
After area under the receiver-operating curve analysis, an ASG score of 17 was highly predictive for reintervention
(area[ 0.8; sensitivity[ 60%; speciﬁcity[ 78%; positive predictive value[ 73%; negative predictive value[ 66%). An
ASG score of 13 was highly predictive for freedom from reintervention (sensitivity [ 93%; speciﬁcity [ 47%; positive
predictive value[ 64%; negative predictive value[ 88%). The lowest ASG score that yielded a 100% reintervention rate was
22. The majority of reinterventions fell into three categories: proximal extension cuff (n[ 18; 40%), distal extension limb
(n[ 7; 16%), and type II endoleak embolization (n[ 13; 29%). Those that received proximal extensions had signiﬁcantly
highermean total ASG score (19 vs 15;P[ .0005),meanneck score (3.28 vs 2.36;P[ .047), andmean aorta score (7.39 vs
2.36; P[ .004). Those that received distal extensions had a signiﬁcantly higher mean iliac score (9.00 vs 6.86; P[ .013),
and those that required an embolization had a signiﬁcantly higher mean aorta branch score (1.92 vs 1.19; P[ .017).
Conclusions: Preoperative total ASG score strongly predicts reintervention after EVAR. Use of a cutoff ASG value
predictive of prohibitive reintervention rates could help guide the decision between endovascular vs open AAA
repair. (J Vasc Surg 2013;58:582-8.)Several large, randomized trials have suggested that
endovascular aneurysm repair (EVAR) can offer patients
with abdominal aortic aneurysms (AAAs) greater than
5-5.5 cm in diameter a surgical option that is both less
invasive and less morbid compared with open repair
(OR).1-3 Long-term follow-up on these patients has shown
that this early advantage is lost by around 2 years postpro-
cedure. This is likely attributed to the increased rate of
graft-related complications and reinterventions in the
EVAR groups compared with the OR groups.4,5 Whenthe Division of Vascular Surgery, Eastern Virginia Medical School.
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://dx.doi.org/10.1016/j.jvs.2013.03.045comparing two groups of EVAR patients (a group deemed
physically ﬁt for either EVAR or OR and a group that
underwent EVAR after being deemed unﬁt for OR), the
rate of graft-related complications and reintervention rates
were remarkably similar, suggesting factors other than
ﬁtness contribute to these outcomes.6
Despite this, advancements in surgical techniques,
newer grafts designed to overcome unfavorable anatomy,
and imaging advances that have allowed for more precise
preoperative planning, have led to the use of EVAR in
patients previously deemed unsuitable because of unfavor-
able aortoiliac anatomy. These technological advances are
expected to lead to a continuous increase in reintervention
rates from the use of EVAR on patients previously consid-
ered anatomically marginal candidates.7
This calls into question the existence of threshold to
answer who is suitable for EVAR and how is suitability
best determined. Rutherford states that despite the worri-
some drawbacks (questionable long-term durability, similar
overall mortality as OR, higher costs, higher reintervention
rates, and the need for an indeﬁnite continuation of surveil-
lance), EVAR is an appropriate treatment in patients with
“suitable anatomy.” Its use works well in conjunction
Table I. ASG score calculation parameters10
Attribute Absent ¼ 0 Mild ¼ 1 Moderate ¼ 2 Severe ¼ 3
Aortic neck
Length (L) L > 25 mm 15 < L < 25 mm 10 < L < 15 mm L < 10 mm
Diameter (d) d < 24 mm 24 < d < 26 mm 26 < d < 28 mm d > 28 mm
Angle >150 150 < angle < 135 135 < angle < 120 Angle < 120
Calciﬁcation/thrombus <25% 25%-50% >50% e
Aortic aneurysm
Angulation and tortuosity
Aortic tortuosity
index (T)
T < 1.05 1.05 < T < 1.15 1.15 < T < 1.2 T > 1.2
Aortic angle (F) 160-180 140-159 120-139 <120
Thrombus 0 <25% 25%-50% >50%
Aortic branch vessels No vessels One lumbar/IMA Two vessels d < 4 mm Two vessels IMA
d > 4 mm
Pelvic perfusion Patent bilateral
IIA
Single IIA occlusion Single IIA occlusion
Contralateral IIA >50%
stenosis
Bilateral IIA occlusion
Iliac artery
Calciﬁcation None <25% vessel length 25%-50% vessel length >50% vessel length
Diameter/occlusive
disease
d > 10 mm
No occlusive
disease
8 < d < 10 mm
No stenosis <7 mm
diameter or >3 cm
long
7 < d < 8 mm
Focal stenosis <7 mm
diameter and <3 cm
in length
d < 7 mm
Stenosis <7-mm diameter
and >3 cm in length
More than one focal
stenosis <7-mm
diameter
Angulation and tortuosity
Iliac tortuosity index (s) s < 1.25 1.25 < s < 1.5 1.5 < s < 1.6 s > 1.6
Iliac angle (f) 160-180 121-159 90-120 <90
Iliac artery sealing zone
Length (L) L > 30 mm 20 < L < 30 mm 10 < L < 20 mm L < 10 mm
Diameter (d) d < 12.5 mm 12.5 < d < 14.5 mm 14.5 < d < 17 mm d > 17 mm
ASG, Anatomic severity grading; IIA, internal iliac artery; IMA, inferior mesenteric artery.
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of AAAs as discussed by the American Association for
Vascular Surgery and the Society for Vascular Surgery
(AAVS/SVS).8,9
Based on these observations, the need has arisen for
a way to stratify candidates for EVAR based on the anatomy
of their aneurysm. In 2002, the ad hoc Committee for
Standardized Reporting Practices in Vascular Surgery of
the AAVS/SVS, deﬁned and categorized the severity of
anatomic factors for AAAs, which they termed the anat-
omic severity grading (ASG) score.10 We have previously
shown a relationship between an ASG score greater than or
equal to 14 with increased procedural difﬁculty, increased
30- day morbidity, and increased hospital costs.11 In this
subsequent study, our aim was to identify if and how pre-
operative ASG score can inﬂuence EVAR reintervention
rates. Determining how ASG score impacts reintervention
rates could further reﬁne patient selection for EVAR by
quantifying and standardizing the term “suitable anatomy.”
This type of improved patient selection would alter long-
term EVAR outcomes by improving long-term endoleak,
rupture, and survival rates of EVAR.
METHODS
We completed a retrospective review of AAA patients
from 2007 through 2011. Patients were identiﬁed using
Current Procedural Terminology (American MedicalAssociation, Chicago, Ill) codes 35081, 35802, 35102,
35103, 35953, 37204, 34800, 34802, 34803, 34804,
34805, 34830, 34831, 34832, 37204, and 75953. Those
who had the three criteria of an index EVAR and subse-
quent reintervention procedure performed by the Division
of Vascular Surgery at Eastern Virginia Medical School
and an M2S (M2S Inc, West Lebanon, NH) three-
dimensional (3D) reconstruction of a preoperative com-
puted tomography scan were selected for inclusion.
Patients were excluded if they underwent a fenestrated
EVAR, or if the indication for EVAR was not an AAA.
Preoperative M2S 3D reconstructions were ordered at
the surgeon’s discretion with some partners ordering
routine preoperative M2S imaging on all patients.
The data collected included age, sex, medical comor-
bidities, past medical history, indication for index proce-
dure, and indication for and type of reintervention.
A secondary procedure was considered a reintervention if
the indication was a local/vascular complication as deﬁned
by the SVS and North American Chapter of the Interna-
tional Society of Cardiovascular Surgery.12 ASG scores
were calculated by two independent blinded reviewers for
the reintervention group from the M2S 3D reconstructions
according to the AAVS/SVS guidelines (Table I).10 The
scores from the reintervention cohort were compared
with a case-controlled cohort of EVAR patients from
a previous study11 that had their index procedure within
Table II. Average ASG score and score components for
reintervention and nonreintervention cohorts
Reintervention Nonreintervention P
Total ASG score 18 13 <.0001
AAA diameter 52 52 .83
Neck length .69 1.62 .0001
Neck diameter .76 .00 <.0001
Neck angle .56 .11 .007
Neck calciﬁcation/
thrombus
1.16 .20 <.0001
Neck score 3.16 1.93 .0006
AAA tortuosity
index
1.49 1.18 .1
AAA angle 1.56 1.04 .01
AAA thrombus 2.39 1.67 .0005
AAA branch vessels 1.76 .84 <.0001
Aorta score 7.13 4.73 <.0001
Internal iliac artery .33 .33 1
Iliac calciﬁcation 1.31 1.36 .8
Diameter/occlusive
disease
1.96 1.18 .001
Iliac tortuosity
index
.91 .58 .03
Iliac angle 1.00 2.31 <.0001
Iliac seal length .67 .24 .04
Iliac seal diameter 1.62 .24 <.0001
Iliac score 7.80 6.24 .003
AAA, Abdominal aortic aneurysm; ASG, anatomic severity grading.
Results are reported as means.
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scores previously calculated via identical methods. ASG
scores and component scores (assigned on a severity scale
of 0 to 3) are reported as averages for each group. AAA
diameter, while not part of the ASG score, was reported
in conjunction with the total ASG score. Values are
recorded in millimeters.
Microsoft Excel 2010 (Microsoft Corporation, Red-
mond, Wash), was used to calculate P values via two-
tailed Student t-tests where a P value of less than .05 was
signiﬁcant. The ASG scores and component scores were
analyzed with respect to reintervention vs nonreinterven-
tion as well as several speciﬁc reintervention types vs those
that did not receive that reintervention. An area under
the receiver-operating characteristic (AUROC) curve was
calculated using Stata/SE 12 (StataCorp, College Station,
Tex). Data collection and image analysis were conducted
with institutional review board approval.
RESULTS
Of the 623 patients treated with EVAR for AAAs from
2007 through 2011, 79 (13%) had reinterventions of
which 45 (7.2%) electively treated patients had preopera-
tive M2S 3D reconstructions available for ASG score
calculation.
The reintervention group had a mean age of 74 years
with 80% male sex. The risk factors included hypertension
(80%), coronary artery disease (31%), cerebrovascular
disease (9%), hypercholesterolemia (69%), chronic obstruc-
tive pulmonary disease (53%), diabetes (20%), and renalinsufﬁciency deﬁned as a creatinine level greater than 1.5
(11%). This group was compared with a case-matched
cohort of 45 EVAR patients that were free from reinter-
vention. The case-matched group had a mean age of 74
(P ¼ .85) and was 80% male (P ¼ 1.00). The risk factors
included hypertension (82%; P ¼ .79), coronary artery
disease (16%; P ¼ .08), cerebrovascular disease (22%;
P ¼ .1), hypercholesterolemia (73%; P ¼ .8), chronic
obstructive pulmonary disease (33%; P ¼ .06), diabetes
(13%; P ¼ .4), and renal insufﬁciency (22%; P ¼ .11). In
the reintervention group, 33 of the 45 were treated with
a Medtronic (Medtronic, Minneapolis, Minn) endograft,
while all 45 in the nonreintervention cohort were treated
withMedtronic endografts. The remaining 12 in the reinter-
vention group were treated with 2 Endologix (Endologix,
Inc, Irvine, Calif), 1 Anaconda (Vascutek, Scotland, UK),
6 Lombard (Lombard Medical Technologies Inc, Wellesley
Hills,Mass), 1 Excluder (W. L. Gore&Associates, Flagstaff,
Ariz), and 2 Aptus (Aptus Endosystems Inc, Sunnyvale,
Calif).
The reintervention group had a mean ASG score of
18 6 5 (range, 8-30) compared with the case-matched
nonreintervention cohort who had a mean ASG score of
13 6 4 (range, 6-21; P < .0001). Neck, aorta, and iliac
component scores were also signiﬁcantly different between
the two groups (mean neck score of 3.16 vs 1.93; P ¼
.0006; mean aorta score of 7.13 vs 4.73; P < .0001; and
mean iliac score of 7.8 vs 6.24; P ¼ .003). The mean
AAA diameter for all patients was 52 mm 6 14 and was
not signiﬁcantly different between the two groups. ASG
score data analysis for the reintervention group vs the non-
reintervention group can be seen in Table II. Average
length of follow-up was 29 months (range, 1-65 months)
for all 90 patients (average of 21 months [range,
1-41 months] for the nonreintervention group and an
average of 37 months [range, 1-65 months] for the reinter-
vention group).
After AUROC analysis, an ASG score of 17 was highly
predictive of reintervention (sensitivity ¼ 60%; speci-
ﬁcity ¼ 78%; positive predictive value ¼ 73%; negative
predictive value ¼ 66%). An ASG score of <17 yielded
a 34% reintervention rate, whereas an ASG score of $17
yielded a 73% reintervention rate (P¼ .0002). The inﬂection
point of the AUROC occurred at an ASG score of 13. This
score was highly predictive for freedom from reintervention
(sensitivity ¼ 93%; speciﬁcity ¼ 47%; positive predictive
value ¼ 64%; negative predictive value ¼ 88%) with a 64%
reintervention rate at an ASG score of 13 and greater and
a 22% reintervention rate at ASG scores below 13 (P <
.0001). The AUROC was 0.8 (95% conﬁdence interval,
0.7-0.9) indicating that the ASG score has moderate discrim-
inatory power.13 The lowest ASG score that yielded a 100%
reintervention rate was 22. The highest ASG score with
100% freedom from reintervention was 7 (Fig 1). Complete
AUROC analysis data can be seen in Fig 2 and Table III.
Themajority of reinterventions fell into three categories:
proximal extension cuff (n¼ 18; 40%), distal extension limb
(n ¼ 7; 16%), and type II endoleak embolization (n ¼ 13;
Fig 1. M2S three-dimensional (3D) reconstructions with an anatomic severity grading (ASG) score of 22 on the left
and 7 on the right.
Fig 2. Area under the receiver-operating characteristic (AUROC)
curve ¼ 0.8 with a cutoff anatomic severity grading (ASG) score
of 17.
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12 (27%) patients: 6 (13%) graft limb thrombectomy
with percutaneous transluminal angioplasty (PTA)/stent-
ing, 2 (4%) graft limb PTA/stenting, and 1 (2%) each of
the following: thromboembolectomy of access artery,
PTA/stenting of the main body of a graft, conversion to
aorto-uni-iliac, and axillary-to-femoral artery bypass.
Further subset analysis was conducted on those that
received a proximal extension cuff, a distal extension limb,
or a type II endoleak embolization. Those that receivedproximal extensions had a signiﬁcantly higher mean total
ASG score (19 vs 15; P ¼ .0005), mean neck score (3.28
vs 2.36; P ¼ .047), and mean aorta score (7.39 vs 2.36;
P ¼ .004) (Table IV). Those that received distal extensions
had signiﬁcantly higher mean iliac score (mean of 9.00
vs 6.68; P ¼ .013) (Table V), and those that required
an endoleak branch embolization had a signiﬁcantly higher
mean aorta branch score (mean of 1.92 vs 1.19; P ¼ .017)
and aorta score (mean of 7.23 vs 5.71; P ¼ .035)
(Table VI).
DISCUSSION
Several studies have shown that as aneurysm size
increases, the risk of graft-related complications
increases.14,15 Yet, intervening on smaller aneurysms before
otherwise indicated does not offer a long-term survival
advantage.16 Interestingly, not only did the reintervention
and the nonreintervention cohorts fail to exhibit a signiﬁcant
difference in aneurysm size, the groups had the same
average aortic size of 52 mm, respectively. It has been re-
ported that aneurysm size also correlates with increased
rate of type Ia endoleaks,14 and our analysis does corrobo-
rate this.
The rest of the anatomic analysis yielded some intuitive
yet surprising results. It has been previously stated that
aneurysms with increased anatomic complexity and more
severe neck anatomy have a higher rate of type Ia endo-
leak.14,17 This has been reafﬁrmed by our ASG score anal-
ysis, as every component of the ASG score as well as the
Table III. Detailed AUROC analysis
ASG score cutoff Sensitivity, % Speciﬁcity, % PPV, % NPV, %
<6 100 0 50 100
6 100 2 50 100
7 100 4 51 100
8 100 11 52 100
9 96 18 54 80
10 96 20 54 82
11 96 36 60 89
12 93 42 62 86
13 93 47 64 88
14 89 51 65 82
15 80 60 67 75
16 71 69 70 70
17 60 78 73 66
18 47 87 78 62
19 42 89 79 60
20 38 96 89 61
21 27 96 86 57
22 18 100 100 55
25 13 100 100 54
27 9 100 100 52
30 2 100 100 51
>30 0 100 100 50
AUROC, Area under the receiver-operating curve; ASG, anatomic severity
grading; NPV, negative predictive value; PPV, positive predictive value.
Table IV. Detailed ASG score analysis for the proximal
extension cohort
Proximal
extension
No proximal
extension P
Total ASG score 19 15 .0005
AAA diameter 58 51 .04
Neck length .83 1.24 .2
Neck diameter 1.06 .21 <.0001
Neck angle .44 .31 .5
Neck calciﬁcation/
thrombus
.94 .61 .1
Neck score 3.28 2.36 .047
AAA tortuosity index 1.50 1.24 .4
AAA angle 1.44 .21 .5
AAA thrombus 2.61 .31 .005
AAA branch vessels 1.83 .61 .008
Aorta score 7.39 2.36 .004
Internal iliac artery .50 .29 .3
Iliac calciﬁcation 1.28 1.35 .8
Diameter/occlusive disease 2.06 1.44 .04
Iliac tortuosity index 1.22 .63 .002
Iliac angle 1.17 1.78 .007
Iliac seal length .89 .35 .04
Iliac seal diameter 1.56 .78 .02
Iliac score 8.67 6.61 .004
AAA, Abdominal aortic aneurysm; ASG, anatomic severity grading.
Results are reported as means.
Table V. Detailed ASG score analysis for the distal
extension cohort
Distal
extension
No distal
extension P
Total ASG score 19 15 .08
AAA diameter 50 52 .7
Neck length .71 1.19 .3
Neck diameter .57 .36 .5
Neck angle .43 .33 .7
Neck calciﬁcation/
thrombus
1.00 .65 .5
Neck score 2.71 2.53 .8
AAA tortuosity index 2.00 1.28 .04
AAA angle 1.43 1.29 .8
AAA thrombus 1.86 2.04 .7
AAA branch vessels 1.86 1.25 .1
Aorta score 7.14 5.83 .2
Internal iliac artery 1.00 .28 .007
Iliac calciﬁcation 1.14 1.35 .5
Diameter/occlusive disease 1.43 1.58 .7
Iliac tortuosity index .86 0.73 .7
Iliac angle .86 1.72 .03
Iliac seal length 1.43 .37 .005
Iliac seal diameter 2.29 .82 .002
Iliac score 9.00 6.86 .01
AAA, Abdominal aortic aneurysm; ASG, anatomic severity grading.
Results are reported as means.
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comparing the proximal extension group with the rest of
the EVAR recipients not requiring a proximal extension.
It is important to note that neck diameter and overall
ASG score are the most signiﬁcant factors determining
the need for proximal extension. Although it has beenreported that neck angulation is an important factor in
determining EVAR outcomes,18 we did not uncover
a signiﬁcant impact of this component of the ASG score
when considering the group that received proximal exten-
sions, although it was signiﬁcant when comparing the rein-
tervention vs nonreintervention groups.
When considering the distal extension group, it is
important to note that only the iliac score is signiﬁcantly
different between those that received a distal extension
and those that did not. This seems to cause an increase
in the total ASG score that is not quite signiﬁcantly
different from those that did not receive a distal extension
cuff. Our interpretation of this is that treacherous iliac
anatomy is the most important indicator of possible future
need of a distal extension cuff for a type Ib endoleak, as it is
the only component of the total ASG score that is signiﬁ-
cantly different. This ﬁnding demonstrates the correlation
of a speciﬁc component score with its related reintervention.
As for the type II endoleak embolization group, it is
most important to note the signiﬁcant difference in the
aorta score, particularly the AAA branch vessels component
of said score. Sampaio et al reported that the presence of
the inferior mesenteric artery along with an increasing
number of patent branch vessels off of the aorta correlated
with increased risk of developing a type II endoleak.19 We
have conﬁrmed their ﬁnding using the ASG score, as the
severity of the branch score increases with the presence of
the inferior mesenteric artery and branch vessels on the
aneurysm. It is also worthwhile to mention that of this
cohort of patients who received embolization as treatment
for a type II endoleak, some of them also received
Table VI. Detailed ASG score analysis for the type II
endoleak embolization cohort
Reintervention Nonreintervention P
Total ASG score 18 15 .03
AAA diameter 60 51 .03
Neck length 0.54 1.26 .04
Neck diameter 0.62 0.34 .3
Neck angle 0.38 0.32 .8
Neck calciﬁcation/
thrombus
1.23 0.58 .02
Neck score 2.77 2.51 .6
AAA tortuosity
index
1.38 1.32 .8
AAA angle 1.77 1.22 .5
AAA thrombus 2.15 2.00 .6
AAA branch vessels 1.92 1.19 .017
Aorta score 7.23 5.71 .035
Internal iliac artery 0.46 0.31 .5
Iliac calciﬁcation 1.23 1.35 .6
Diameter/occlusive
disease
1.38 1.60 .5
Iliac tortuosity
index
1.38 0.64 .0006
Iliac angle 0.62 1.83 >.0005
Iliac seal length 0.77 0.40 .2
Iliac seal diameter 2.54 0.66 >.0001
Iliac score 8.38 6.79 .03
AAA, Abdominal aortic aneurysm; ASG, anatomic severity grading.
Results are reported as means.
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artiﬁcially signiﬁcant difference in the iliac score and its
components as well as the total ASG score. It would be
worthwhile to examine a group of patients that had only
a type II endoleak embolization. However, for our study,
a sample size of 13 was already fairly small and removing
those patients who had both reinterventions would have
weakened the statistical signiﬁcance of the other differences
seen in the ASG score components.
Finally, when considering the original cohorts (reinter-
vention vs nonreintervention), nearly every component of
the ASG score is signiﬁcantly different. Perhaps the most
telling is the total score itself. Our AUROC analysis clearly
showed that the ASG score is a good indicator in predicting
reintervention. We have shown that at ASG scores of 13
and lower is highly predictive of freedom from reinterven-
tion, which correlates with our previous published data
demonstrating that an ASG score of less than 14 also corre-
lated with less operative difﬁculty, better 30-day outcomes,
and smaller hospital costs.11
One of the major weaknesses in our study is the small
sample size of the individual reintervention types. This is
especially evident in the type II endoleak cohort and
is explained above. It is possible that with larger sample
sizes, we would have yielded similar conclusions to
previous studies regarding speciﬁc anatomic components
as risk factors for endoleak. Our sample size was also
limited due to the necessity for a preoperative M2S 3D
reconstruction to calculate the ASG score. This require-
ment may have resulted in an underrepresentation ofpatients with chronic renal insufﬁciency and also rendered
us unable to control for endograft type because of the rela-
tively small number of patients that had a preoperative
M2S. We continue to expand on our database to gain
enough power to perform multivariate analysis on the
different reintervention types. A potential weakness also
exists in the application of our AUROC results to the pop-
ulation as a whole. The data represent a group of 45 EVAR
patients with a reintervention compared with a cohort of 45
patients without reinterventions, resulting in a reinterven-
tion rate of 50%, which is much higher than our real overall
reintervention rate of 13%. We do believe that our results
open the door to the applicability of the ASG score in
everyday practice, and it certainly requires a validation study
on a larger population with a reintervention rate closer to
13%. Additionally, a future study should attempt to eluci-
date any correlation of ASG score with the overall cost of
AAA treatment, as several patients received more than one
reintervention.
In conclusion, preoperative total ASG score strongly
predicts reintervention after EVAR and could be a powerful
tool for vascular surgeons and their patients as they decide
on the proper course of treatment. It quantiﬁes AAA severity
in a standard numerical form that is easy to interpret. We
have shown that the ASG score correlates not only with
risk of reintervention but also the type of reintervention
that may be needed. Use of a cutoff ASG score value predic-
tive of prohibitive reintervention rates could help guide the
decision between endovascular vs open AAA repair and
perhaps render AAA treatment more cost-effective.
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